Framycetin

Jump to: navigation, search
Framycetin.png
Framycetin
Systematic (IUPAC) name
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)
-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)
-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)
-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy
-5-(hydroxymethyl)oxolan-2-yl]oxy
-3-hydroxycyclohexyl]oxyoxane-3,4-diol
Identifiers
CAS number  ?
ATC code R01AX08
PubChem 8378
Chemical data
Formula C23H46N6O13 
Mol. mass 614.644 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Framycetin is a nasal preparation.



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages